相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Role of the miR-301a/Fra-2/GLIPR1 axis in lung cancer cisplatin resistance
Gian Luca Rampioni Vinciguerra et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2023)
AP-1 leads the way in lung cancer transformation
James Kim et al.
DEVELOPMENTAL CELL (2022)
Epigenetic basis of oncogenic-Kras-mediated epithelial-cellular proliferation and plasticity
Preetish Kadur Lakshminarasimha Murthy et al.
DEVELOPMENTAL CELL (2022)
The Fra-1/AP-1 Oncoprotein: From the Undruggable Transcription Factor to Therapeutic Targeting
Laura Casalino et al.
CANCERS (2022)
SP600125 Enhances Temperature-Controlled Repeated Thermal Stimulation-Induced Neurite Outgrowth in PC12-P1F1 Cells
You-Ran Luo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
JUNB-FBXO21-ERK axis promotes cartilage degeneration in osteoarthritis by inhibiting autophagy
Zhiming Lin et al.
AGING CELL (2021)
Targeting AKR1B1 inhibits glutathione de novo synthesis to overcome acquired resistance to EGFR-targeted therapy in lung cancer
Ke-Ren Zhang et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Blocking Fra-1 sensitizes triple-negative breast cancer to PARP inhibitor
Dandan Song et al.
CANCER LETTERS (2021)
FOSL1 promotes metastasis of head and neck squamous cell carcinoma through super-enhancer-driven transcription program
Ming Zhang et al.
MOLECULAR THERAPY (2021)
JUNB suppresses distant metastasis by influencing the initial metastatic stage
Juliane Wutschka et al.
CLINICAL & EXPERIMENTAL METASTASIS (2021)
JunD, not c-Jun, is the AP-1 transcription factor required for Ras-induced lung cancer
E. Josue Ruiz et al.
JCI INSIGHT (2021)
Regulation of T cell differentiation by the AP-1 transcription factor JunB
Takaharu Katagiri et al.
IMMUNOLOGICAL MEDICINE (2021)
CDK4/6 inhibition reprograms the breast cancer enhancer landscape by stimulating AP-1 transcriptional activity
April C. Watt et al.
NATURE CANCER (2021)
MyD88 mediates colorectal cancer cell proliferation, migration and invasion via NF-kappa B/AP-1 signaling pathway
Guangwei Zhu et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2020)
Cyclin-dependent kinase 4 and 6 inhibitors for hormone receptor-positive breast cancer: past, present, and future
Laura M Spring et al.
LANCET (2020)
TGFβ and EGF signaling orchestrates the AP-1-and p63 transcriptional regulation of breast cancer invasiveness
Anders Sundqvist et al.
ONCOGENE (2020)
YAP and AP-1 Cooperate to Initiate Pancreatic Cancer Development from Ductal Cells in Mice
Jaeoh Park et al.
CANCER RESEARCH (2020)
Doxycycline has distinct apicoplast-specific mechanisms of antimalarial activity
Megan Okada et al.
ELIFE (2020)
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
Tony S. K. Mok et al.
LANCET (2019)
AP-1 Transcription Factors as Regulators of Immune Responses in Cancer
Vasileios Atsaves et al.
CANCERS (2019)
c-Jun overexpression in CAR T cells induces exhaustion resistance
Rachel C. Lynn et al.
NATURE (2019)
JUNB governs a feed-forward network of TGFβ signaling that aggravates breast cancer invasion
Anders Sundqvist et al.
NUCLEIC ACIDS RESEARCH (2018)
A selective c-Fos/AP-1 inhibitor prevents cartilage destruction and subsequent osteophyte formation
Hiraku Motomura et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
c-Jun/AP-1 overexpression reprograms ERα signaling related to tamoxifen response in ERα-positive breast cancer
Huan He et al.
ONCOGENE (2018)
Targeting activator protein 1 signaling pathway by bioactive natural agents: Possible therapeutic strategy for cancer prevention and intervention
Devesh Tewari et al.
PHARMACOLOGICAL RESEARCH (2018)
AP-1 confers resistance to anti-cancer therapy by activating XIAP
Yuan Wang et al.
Oncotarget (2018)
The Role of Activator Protein-1 (AP-1) Family Members in CD30-Positive Lymphomas
Ines Garces de los Fayos Alonso et al.
CANCERS (2018)
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
P. Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
JUN-Mediated Downregulation of EGFR Signaling Is Associated with Resistance to Gefitinib in EGFR-mutant NSCLC Cell Lines
Kian Kani et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection
Justin Eyquem et al.
NATURE (2017)
Selective activator protein-1 inhibitor T-5224 prevents lymph node metastasis in an oral cancer model
Daisuke Kamide et al.
CANCER SCIENCE (2016)
Romidepsin for the treatment of non-Hodgkin's lymphoma
Victor Y. Yazbeck et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2015)
Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth
Francesca Zanconato et al.
NATURE CELL BIOLOGY (2015)
4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors
Adrienne H. Long et al.
NATURE MEDICINE (2015)
FRA-1 as a driver of tumour heterogeneity: a nexus between oncogenes and embryonic signalling pathways in cancer
A. S. Dhillon et al.
ONCOGENE (2015)
Molecular and cellular insights into T cell exhaustion
E. John Wherry et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Discovery of thienopyrimidine-based FLT3 inhibitors from the structural modification of known IKKβ inhibitors
Chun-Ho Park et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Genome-wide Profiling of AP-1-Regulated Transcription Provides Insights into the Invasiveness of Triple-Negative Breast Cancer
Chunyan Zhao et al.
CANCER RESEARCH (2014)
AP-1/c-Jun transcription factors: Regulation and function in malignant melanoma
Melanie Kappelmann et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2014)
Widespread FRA1-Dependent Control of Mesenchymal Transdifferentiation Programs in Colorectal Cancer Cells
Jeannine Diesch et al.
PLOS ONE (2014)
Multiple cells-of-origin of mutant K-Ras-induced mouse lung adenocarcinoma
Kate D. Sutherland et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Basal-Like and Triple-Negative Breast Cancers Searching for Positives Among Many Negatives
Prasanna Alluri et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2014)
Protein Kinase C α Is a Central Signaling Node and Therapeutic Target for Breast Cancer Stem Cells
Wai Leong Tam et al.
CANCER CELL (2013)
Specific interactions between Smad proteins and AP-1 components determine TGFβ-induced breast cancer cell invasion
A. Sundqvist et al.
ONCOGENE (2013)
Constitutive AP-1 Activity and EBV Infection Induce PD-L1 in Hodgkin Lymphomas and Posttransplant Lymphoproliferative Disorders: Implications for Targeted Therapy
Michael R. Green et al.
CLINICAL CANCER RESEARCH (2012)
Activator protein-1 (AP-1) signalling in human atherosclerosis: results of a systematic evaluation and intervention study
C. Arnoud Meijer et al.
CLINICAL SCIENCE (2012)
Activator protein 1 suppresses antitumor T-cell function via the induction of programmed death 1
Gang Xiao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Vorinostat-Induced Apoptosis in Mantle Cell Lymphoma Is Mediated by Acetylation of Proapoptotic BH3-Only Gene Promoters
Silvia Xargay-Torrent et al.
CLINICAL CANCER RESEARCH (2011)
Inhibition of c-Jun N-Terminal Kinase Attenuates Low Shear Stress-Induced Atherogenesis in Apolipoprotein E-Deficient Mice
Juan Wang et al.
MOLECULAR MEDICINE (2011)
AP-1-The Jun proteins: Oncogenes or tumor suppressors in disguise?
Eitan Shaulian
CELLULAR SIGNALLING (2010)
ERK2 but Not ERK1 Induces Epithelial-to-Mesenchymal Transformation via DEF Motif-Dependent Signaling Events
Sejeong Shin et al.
MOLECULAR CELL (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
OPINION Emerging roles of ATF2 and the dynamic AP1 network in cancer
Pablo Lopez-Bergami et al.
NATURE REVIEWS CANCER (2010)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
Angiotensin II promotes poly(ADP-ribosyl)ation of c-Jun/c-Fos in cardiac fibroblasts
Dan Huang et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2009)
Quassinoid Inhibition of AP-1 Function Does Not Correlate with Cytotoxicity or Protein Synthesis Inhibition
John A. Beutler et al.
JOURNAL OF NATURAL PRODUCTS (2009)
PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro
Richard S. Finn et al.
BREAST CANCER RESEARCH (2009)
Ubiquitin-independent- versus ubiquitin-dependent proteasomal degradation of the c-Fos and Fra-1 transcription factors: Is there a unique answer?
Jihane Basbous et al.
BIOCHIMIE (2008)
c-Jun N-Terminal Kinase 2 Deficiency Protects Against Hypercholesterolemia-Induced Endothelial Dysfunction and Oxidative Stress
Elena Osto et al.
CIRCULATION (2008)
Enhanced expression and activation of pro-inflammatory transcription factors distinguish aneurysmal from atherosclerotic aorta: IL-6- and IL-8-dominated inflammatory responses prevail in the human aneurysm
Jan H. N. Lindeman et al.
CLINICAL SCIENCE (2008)
Treatment of arthritis with a selective inhibitor of c-Fos/activator protein-1
Yukihiko Aikawa et al.
NATURE BIOTECHNOLOGY (2008)
Multiple facets of junD gene expression are atypical among AP-1 family members
J. M. Hernandez et al.
ONCOGENE (2008)
Heterodimerization with jun family members regulates c-fos nucleocytoplasmic traffic
Cecile E. Malnou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
First-into-man phase I and pharmacokinetic study of XR5944.14, a novel agent with a unique mechanism of action
W. Verborg et al.
BRITISH JOURNAL OF CANCER (2007)
Molecular signature of CD8+ T cell exhaustion during chronic viral infection
E. John Wherry et al.
IMMUNITY (2007)
Simultaneous generation of fra-2 conditional and fra-2 knock-out mice
Robert Eferl et al.
GENESIS (2007)
P68 RNA helicase mediates PDGF-induced epithelial mesenchymal transition by displacing axin from β-catenin
Liuqing Yang et al.
CELL (2006)
Anticancer activities of histone deacetylase inhibitors
Jessica E. Bolden et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
The Fos family of transcription factors and their role in tumourigenesis
K Milde-Langosch
EUROPEAN JOURNAL OF CANCER (2005)
Down-regulation of c-Fos/c-Jun AP-1 Dimer activity by sumoylation
G Bossis et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Mitogen regulated induction of FRA-1 proto-oncogene is controlled by the transcription factors binding to both serum and TPA response elements
P Adiseshaiah et al.
ONCOGENE (2005)
Phosphorylation of c-fos by members of the p38 MAPK family - Role in the AP-1 response to UV light
T Tanos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Selective regulation of c-jun gene expression by mitogen-activated protein kinases via the 12-O-tetradecanoylphorbol-13-acetate-responsive element and myocyte enhancer factor 2 binding sites
M Kayahara et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Histone deacetylase inhibitors in programmed cell death and cancer therapy
PA Marks et al.
CELL CYCLE (2005)
Poly(ADP-ribose) - The most elaborate metabolite of NAD
A Burkle
FEBS JOURNAL (2005)
Differential regulation of activator protein-1 and heat shock factor-1 in myocardial ischemia and reperfusion injury: role of poly(ADP-ribose) polymerase-1
B Zingarelli et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
Dominant-negative mutant of c-Jun gene transfer: a novel therapeutic strategy for colorectal cancer
R Suto et al.
GENE THERAPY (2004)
Novel DNA bis-intercalation by MLN944, a potent clinical bisphenazine anticancer drug
JX Dai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
c-Jun-deficient cells undergo premature senescence as a result of spontaneous DNA damage accumulation
A MacLaren et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
The design and synthesis of novel orally active inhibitors of AP-1 and NF-κB mediated transcriptional activation. SAR of in vitro and in vivo studies
MSS Palanki et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Role of the Fos family members, c-Fos, Fra-1 and Fra-2, in the regulation of cell motility
V Tkach et al.
ONCOGENE (2003)
A reinvestigation of the multisite phosphorylation of the transcription factor c-Jun
S Morton et al.
EMBO JOURNAL (2003)
ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility
E Vial et al.
CANCER CELL (2003)
Poly(ADP-ribose) polymerase-1 regulates activation of activator protein-1 in murine fibroblasts
TL Andreone et al.
JOURNAL OF IMMUNOLOGY (2003)
Cell cycle promoting activity of JunB through cyclin A activation
S Andrecht et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-κB
S Mathas et al.
EMBO JOURNAL (2002)
Promoter specificity and biological activity of tethered AP-1 dimers
L Bakiri et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity
Y Chinenov et al.
ONCOGENE (2001)
The mammalian UV response: c-jun induction is required for exit from p53-imposed growth arrest
E Shaulian et al.
CELL (2000)
JunD protects cells from p53-dependent senescence and apoptosis
JB Weitzman et al.
MOLECULAR CELL (2000)
Expression of Jun family members in human colorectal adenocarcinoma
HL Wang et al.
CARCINOGENESIS (2000)
Base excision repair is impaired in mammalian cells lacking poly(ADP-ribose) polymerase-1
F Dantzer et al.
BIOCHEMISTRY (2000)
c-Jun-dependent CD95-L expression is a rate-limiting step in the induction of apoptosis by alkylating agents
A Kolbus et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
分享论文
